Seller record · Telehealth service
ElitePhysiqMD
Fails 3 of 8 criteria. S2, prescription gating: The add-to-cart button leads to a card checkout that states the patient intake form is displayed only after the order is placed. 2 more criteria also fail; see the table below.
At a glance
ElitePhysiqMDTelehealth service
- Price
- Semaglutide $199 one-time or $179.10 a month on subscription
- Sells
- compounded semaglutide, compounded tirzepatide, compounded retatrutide, and 10 more
- FDA letters
- None on file
Telehealth service. Passes 5 of 8 criteria. Recorded against Standard v1.1.
A telehealth service selling compounded semaglutide, tirzepatide and retatrutide beside an 18-peptide catalog that includes sermorelin, tesamorelin, BPC-157, NAD+ and PT-141, with a live video visit before prescribing. Its product pages go to a checkout that takes payment before the intake form.
Operating entity ElitePhysiqMD Group, Inc. The brand sells from 2 storefronts of its own, recorded here as one entry: ElitePhysiqMD's website, and 1 other domain of its own.
Dispositions
| Code | Criterion | Disposition | Where it appears |
|---|---|---|---|
| S1 | Prescriber requirement | PASS | ElitePhysiqMD's semaglutide product page; ElitePhysiqMD's checkout |
| S2 | Prescription gating | FAIL | ElitePhysiqMD's semaglutide product page; ElitePhysiqMD's checkout |
| S3 | Pharmacy identification | FAIL | ElitePhysiqMD's website; ElitePhysiqMD's semaglutide product page |
| S4 | Compounding disclosure | PASS | ElitePhysiqMD's semaglutide product page; ElitePhysiqMD's retatrutide product page |
| S5 | Analytical documentation | FAIL | ElitePhysiqMD's BPC-157 product page; ElitePhysiqMD's platform terms conditions |
| S6 | Business address | PASS | ElitePhysiqMD's web terms of use page; ElitePhysiqMD's contact us page |
| S7 | Price disclosure | PASS | ElitePhysiqMD's semaglutide product page; ElitePhysiqMD's tirzepatide product page; ElitePhysiqMD's retatrutide product page; ElitePhysiqMD's sermorelin product page |
| S8 | Enforcement status | PASS | FDA warning-letter index |
Evidence, criterion by criterion
The evidence behind each disposition in the table above, where it appears, and its date.
Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, compounded retatrutide, sermorelin, tesamorelin, NAD+, BPC-157, PT-141, GHK-Cu, glutathione, CJC-1295 and ipamorelin, DSIP, testosterone.
Other sellers of the same products
Who sells semaglutideWho sells tirzepatideWho sells sermorelinWho sells NAD+Who sells glutathioneWho sells PT-141Who sells GHK-CuWho sells tesamorelinWho sells BPC-157Who sells ipamorelinWho sells retatrutide
Unpaid link. ElitePhysiqMD does not pay the site, and nothing is earned when it is used. Funding.
Visit ElitePhysiqMDDispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.